Document is current

Dasatinib + Gefitinib, a non platinum-based combination with enhanced growth inhibitory, anti-migratory and anti-invasive potency against human ovarian cancer cells

Crossref DOI link: https://doi.org/10.1186/s13048-017-0319-2

Published Online: 2017-04-26

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy